Gene · 4883
Papers1,657
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,657
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A single cell transcriptional roadmap of human pacemaker cell differentiation. | Elife | 2022 | 36217819 | PubTator, text mining | PubMed |
| Genome-wide association study for Chagas Cardiomyopathy identify a new risk locus on chromosome 18 associated with an immune-related protein and transcriptional signature. | PLoS Negl Trop Dis | 2022 | 36215317 | PubTator, text mining | PubMed |
| Next Generation Sequencing for Potential Regulated Genes and Micro-RNAs of Early Growth Response-1 in the Esophageal Squamous Cell Carcinoma. | Protein J | 2022 | 36207572 | PubTator, text mining | PubMed |
Physiological and transcriptomic analyses revealed gene networks involved in heightened resistance against tomato yellow leaf curl virus infection in salicylic acid and jasmonic acid treated tomato plants. | Front Microbiol | 2022 | 36187991 | PubTator, text mining | PubMed |
| Identification of orphan ligand-receptor relationships using a cell-based CRISPRa enrichment screening platform. | Elife | 2022 | 36178190 | PubTator, text mining | PubMed |
| Loss of full-length dystrophin expression results in major cell-autonomous abnormalities in proliferating myoblasts. | Elife | 2022 | 36164827 | PubTator, text mining | PubMed |
| Mechanism of electroacupuncture and herb-partitioned moxibustion on ulcerative colitis animal model: A study based on proteomics. | World J Gastroenterol | 2022 | 36161055 | PubTator, text mining | PubMed |
| Inflammation and immunity connect hypertension with adverse COVID-19 outcomes. | Front Genet | 2022 | 36160003 | PubTator, text mining | PubMed |
| Sarcomatoid-associated gene risk index for clear cell renal cell carcinoma. | Front Genet | 2022 | 36159988 | PubTator, text mining | PubMed |
| From Snake Venoms to Therapeutics: A Focus on Natriuretic Peptides. | Pharmaceuticals (Basel) | 2022 | 36145374 | PubTator, text mining | PubMed |
| Inhibition of KRAS, MEK and PI3K Demonstrate Synergistic Anti-Tumor Effects in Pancreatic Ductal Adenocarcinoma Cell Lines. | Cancers (Basel) | 2022 | 36139627 | PubTator, text mining | PubMed |
| Killer-Cell Immunoglobulin-like Receptor Diversity in an Admixed South American Population. | Cells | 2022 | 36139351 | PubTator, text mining | PubMed |
| Molecular Mechanism of Blood Pressure Regulation through the Atrial Natriuretic Peptide. | Biology (Basel) | 2022 | 36138830 | PubTator, text mining | PubMed |
| Molecular mechanisms for the prevention and promoting the recovery from ischemic stroke by nutraceutical laminarin: A comparative transcriptomic approach. | Front Nutr | 2022 | 36118760 | PubTator, text mining | PubMed |
| Partial prevention of glucocorticoid-induced osteocyte deterioration in young male mice with osteocrin gene therapy. | iScience | 2022 | 36105586 | PubTator, text mining | PubMed |
| B-Type Natriuretic Peptide (BNP) Revisited-Is BNP Still a Biomarker for Heart Failure in the Angiotensin Receptor/Neprilysin Inhibitor Era? | Biology (Basel) | 2022 | 36101415 | PubTator, text mining | PubMed |
| CNP, the Third Natriuretic Peptide: Its Biology and Significance to the Cardiovascular System. | Biology (Basel) | 2022 | 36101368 | PubTator, text mining | PubMed |
| RUNX regulated immune-associated genes predicts prognosis in breast cancer. | Front Genet | 2022 | 36092942 | PubTator, text mining | PubMed |
| Bioinformatics analysis of the prognostic and immunotherapeutic significance of NPRL2 in stomach adenocarcinoma. | J Gastrointest Oncol | 2022 | 36092347 | PubTator, text mining | PubMed |
| A miRNA-Based Prognostic Model to Trace Thyroid Cancer Recurrence. | Cancers (Basel) | 2022 | 36077665 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4883/papers?page=14